Lundbeck Gets EU Antitrust Complaint on Citalopram Deals

H. Lundbeck A/S, the Nordic region’s second-largest drugmaker, was sent a complaint by European Union antitrust regulators over agreements with rivals that may have held back sales of cheaper generic drugs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.